🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 18 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
28/06/2013 38,12 38,60 37,60 38,04 -0,21% 2,62% 5.962.200
27/06/2013 39,87 39,95 37,25 38,12 -4,05% 6,77% 3.345.400
26/06/2013 39,95 40,48 39,11 39,73 +0,00% 3,43% 1.498.900
25/06/2013 38,79 39,90 38,60 39,73 +3,03% 3,35% 1.496.500
24/06/2013 37,74 38,99 36,25 38,56 +1,18% 7,26% 1.567.200
21/06/2013 39,59 40,10 37,11 38,11 -3,54% 7,55% 2.237.700
20/06/2013 39,65 40,39 38,52 39,51 -0,68% 4,72% 1.924.200
19/06/2013 40,51 41,25 39,02 39,78 +4,27% 5,50% 3.238.200
18/06/2013 37,70 38,46 36,95 38,15 +1,03% 4,01% 856.700
17/06/2013 38,60 38,81 37,59 37,76 -1,90% 3,16% 744.300
14/06/2013 37,70 39,00 37,26 38,49 +0,03% 4,62% 736.000
13/06/2013 37,26 38,77 36,91 38,48 +3,08% 4,99% 760.200
12/06/2013 38,90 39,28 37,05 37,33 -3,47% 5,73% 978.700
11/06/2013 37,72 39,00 36,80 38,67 +2,22% 5,83% 684.900
10/06/2013 37,99 39,23 37,25 37,83 -0,03% 5,21% 914.700
07/06/2013 36,67 37,90 36,59 37,84 +3,76% 3,57% 949.400
06/06/2013 35,10 36,65 34,90 36,47 +3,26% 4,99% 929.700
05/06/2013 34,59 35,97 33,62 35,32 +1,15% 6,79% 1.115.700
04/06/2013 35,90 36,17 34,41 34,92 -2,87% 4,90% 969.000
03/06/2013 35,19 35,99 34,10 35,95 +1,70% 5,37% 1.232.800
31/05/2013 36,40 37,58 35,28 35,35 -6,43% 6,32% 1.901.500
30/05/2013 39,52 40,56 36,95 37,78 -4,26% 9,13% 2.588.400
29/05/2013 38,54 39,72 38,39 39,46 +1,41% 3,45% 696.600
28/05/2013 38,75 39,33 38,00 38,91 +2,88% 3,43% 1.221.500
24/05/2013 38,19 38,85 37,50 37,82 -0,32% 3,53% 973.700
23/05/2013 35,57 38,33 35,14 37,94 +4,46% 8,97% 1.294.600
22/05/2013 36,76 37,70 35,54 36,32 -0,90% 5,88% 1.275.500
21/05/2013 37,01 37,41 35,27 36,65 -1,29% 5,78% 1.035.200
20/05/2013 37,02 37,80 36,90 37,13 +0,60% 2,43% 1.160.500
17/05/2013 35,51 37,11 35,14 36,91 +3,94% 5,55% 1.378.100